Health
Mefloquine shows potential as anti-SARS-CoV-2 drug – News-Medical.Net
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome…
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral loadin vitro. The study is currently available on the bioRxiv* preprint server.
The recent pandemic of coronavirus disease 2019 (COVID-19) has put a substantial amount of burden on healthcare…
-
General20 hours agoTrump eyes Tesla subsidies, Musk says ‘cut it all’
-
Business13 hours agoGuess which surging ASX All Ords stock just earned an upgrade from Macquarie
-
Noosa News17 hours agoKoala adventures | Noosa Today
-
Noosa News14 hours agoFlights cancelled as Ekka-like winds buffet south-east Queensland; Ex-Brisbane Lions sponsor goes bust, leaving 200 workers in limbo